Abstract
The importance of nucleoside metabolism in brain followed the recognition that i) adult nervous system maintains its nucleotide pools in the proper qualitative and quantitative balance by salvaging preformed purine and pyrimidine rings, rather than by synthesizing nucleosides de novo from simple precursors, ii) adenosine, a purine nucleoside, acts as an extracellular signal, and exerts its protective effects by interacting with plasmamembrane bound purinergic G-protein coupled P2X receptors. More recently uridine, a pyrimidine nucleoside, has received considerable attention. Most of the uridine content of brain is supplied by its uptake from the plasma. An increasing body of evidence suggests that uridine exerts its function intracellularly in three distinct ways. It is phosphorylated to UTP, a pyrimidine nucleotide acting as a precursors for RNA and DNA synthesis, and as an extracellular neurotrophic signal. In combination with the -3 fatty acid decosahexaenoic acid and choline, uridine accelerates formation of synaptic membrane, being an obligatory precursor for CDP-choline synthesis. Finally, uridine can preserve the ATP pool via the conversion of its ribose-1-phosphate moiety into energetic intermediates of glycolysis. This article summarizes our present knowledge on uridine metabolism in the brain, with special emphasis on the mechanisms maintaining its intracellular homeostasis and on the cross talk between intracellular and extracellular uridine metabolism.
Keywords: Extra- and intracellular uridine metabolism, homeostasis of uridine, uridine functions, uridine recycling in brain, uridine
Graphical Abstract
Current Metabolomics
Title:Metabolic Regulation of Uridine in the Brain
Volume: 3 Issue: 1
Author(s): Piero L. Ipata and Rossana Pesi
Affiliation:
Keywords: Extra- and intracellular uridine metabolism, homeostasis of uridine, uridine functions, uridine recycling in brain, uridine
Abstract: The importance of nucleoside metabolism in brain followed the recognition that i) adult nervous system maintains its nucleotide pools in the proper qualitative and quantitative balance by salvaging preformed purine and pyrimidine rings, rather than by synthesizing nucleosides de novo from simple precursors, ii) adenosine, a purine nucleoside, acts as an extracellular signal, and exerts its protective effects by interacting with plasmamembrane bound purinergic G-protein coupled P2X receptors. More recently uridine, a pyrimidine nucleoside, has received considerable attention. Most of the uridine content of brain is supplied by its uptake from the plasma. An increasing body of evidence suggests that uridine exerts its function intracellularly in three distinct ways. It is phosphorylated to UTP, a pyrimidine nucleotide acting as a precursors for RNA and DNA synthesis, and as an extracellular neurotrophic signal. In combination with the -3 fatty acid decosahexaenoic acid and choline, uridine accelerates formation of synaptic membrane, being an obligatory precursor for CDP-choline synthesis. Finally, uridine can preserve the ATP pool via the conversion of its ribose-1-phosphate moiety into energetic intermediates of glycolysis. This article summarizes our present knowledge on uridine metabolism in the brain, with special emphasis on the mechanisms maintaining its intracellular homeostasis and on the cross talk between intracellular and extracellular uridine metabolism.
Export Options
About this article
Cite this article as:
Ipata L. Piero and Pesi Rossana, Metabolic Regulation of Uridine in the Brain, Current Metabolomics 2015; 3 (1) . https://dx.doi.org/10.2174/2213235X03666150309233012
DOI https://dx.doi.org/10.2174/2213235X03666150309233012 |
Print ISSN 2213-235X |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-2368 |
Related Articles
-
Cellular Membranes and Lipid-Binding Domains as Attractive Targets for Drug Development
Current Drug Targets Design and Evaluation of Semicarbazones and Thiosemicarbazones as Novel Anticonvulsants
Central Nervous System Agents in Medicinal Chemistry Commentary [Research Highlights (Making Sense Out of Antisense in Huntington’s Disease)]
CNS & Neurological Disorders - Drug Targets Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies
Current Pharmaceutical Design Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
Current Alzheimer Research Beyond Acetylcholinesterase Inhibitors for Treating Alzheimer's Disease: α7-nAChR Agonists in Human Clinical Trials
Current Pharmaceutical Design Current Approaches for Drug Delivery to Central Nervous System
Current Drug Delivery Cytotoxicity and Anti-proliferative Properties of Heterocyclic Compounds Derived from Progesterone
Anti-Cancer Agents in Medicinal Chemistry Search for Molecular Basis of Antifungal Activity of Thiosemicarbazide Derivatives: A Combined in vitro Antifungal and Enzymatic Studies with in Silico Docking
Letters in Drug Design & Discovery HTLV-1 Associated Neurological Disorders
Current Topics in Medicinal Chemistry Drug Repositioning: A Unique Approach to Refurbish Drug Discovery
Current Drug Discovery Technologies Development of Nitrile-Based Peptidic Inhibitors of Cysteine Cathepsins
Current Topics in Medicinal Chemistry HCN Pacemaker Channels and Pain: A Drug Discovery Perspective
Current Pharmaceutical Design Application of NMR Screening in Drug Discovery
Current Topics in Medicinal Chemistry Comparative Anatomy, Physiology and In Vitro Models of the Blood-Brain and Blood-Retina Barrier
Current Medicinal Chemistry - Central Nervous System Agents Structurally Unprecedented Metabolites from Marine Sponges
Current Organic Chemistry Design, Synthesis, Characterization, Molecular Docking, ADME Properties and <i>In Vivo</i> Antipsychotic Activity of Aripiprazole Related Drugs Candidates
Letters in Drug Design & Discovery Editorial [Hot Topic:Ion Channels as a Target for Drug Design (Executive Editor: Kwok-Keung Tai)]
Current Pharmaceutical Design Bis-dihydroisoxazolines: Synthesis, Structural Elucidation, Antimicrobial Evaluation, and DNA Photocleavage Assay
Current Organic Synthesis Formulation Strategies of Nano Lipid Carrier for Effective Brain Targeting of Anti-AD Drugs
Current Pharmaceutical Design